- Home
- RPTX vs UCL Comparison
RPTX vs UCL Comparison
Compare RPTX & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- UCL
- Stock Information
- Founded
- RPTX 2016
- UCL 2014
- Country
- RPTX Canada
- UCL Hong Kong
- Employees
- RPTX N/A
- UCL N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- UCL Telecommunications Equipment
- Sector
- RPTX Health Care
- UCL Consumer Discretionary
- Exchange
- RPTX Nasdaq
- UCL Nasdaq
- Market Cap
- RPTX 58.8M
- UCL 47.0M
- IPO Year
- RPTX 2020
- UCL 2020
- Fundamental
- Price
- RPTX $1.36
- UCL $1.54
- Analyst Decision
- RPTX Strong Buy
- UCL
- Analyst Count
- RPTX 3
- UCL 0
- Target Price
- RPTX $4.50
- UCL N/A
- AVG Volume (30 Days)
- RPTX 190.7K
- UCL 82.0K
- Earning Date
- RPTX 05-13-2025
- UCL 05-21-2025
- Dividend Yield
- RPTX N/A
- UCL N/A
- EPS Growth
- RPTX N/A
- UCL N/A
- EPS
- RPTX N/A
- UCL 0.09
- Revenue
- RPTX $1,073,000.00
- UCL $92,256,000.00
- Revenue This Year
- RPTX N/A
- UCL $4.93
- Revenue Next Year
- RPTX N/A
- UCL N/A
- P/E Ratio
- RPTX N/A
- UCL $18.01
- Revenue Growth
- RPTX N/A
- UCL 7.65
- 52 Week Low
- RPTX $0.89
- UCL $0.80
- 52 Week High
- RPTX $4.29
- UCL $3.30
- Technical
- Relative Strength Index (RSI)
- RPTX 55.96
- UCL 68.85
- Support Level
- RPTX $1.33
- UCL $1.59
- Resistance Level
- RPTX $1.41
- UCL $1.90
- Average True Range (ATR)
- RPTX 0.06
- UCL 0.14
- MACD
- RPTX -0.01
- UCL 0.04
- Stochastic Oscillator
- RPTX 55.56
- UCL 63.08
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.